Santen, Massachusetts Eye and Ear and Ulster University have formed a research initiative to investigate and develop novel therapies for the treatment of glaucoma, according to a press release.
The initiative aims to prevent vision impairment or loss by “slowing, reversing or preventing” damage to the optic nerve, the release said.
“Our research aims to determine if targeting a component of the immune system called the NLRP3 inflammasome, with a novel biologic we developed in collaboration with Dr. Victoria McGilligan, will stop the degeneration of optic nerve cells and help